Quantification of subjective perceptions, such as smell and taste, and correlating it with medical conditions will add an additional dimension into diease diagnosis, particularly those that relates to respiratory symptoms. Leveraging on COVID-19 as an initial case study for the development of standardized test kits for smell and taste. Further implications are also expected in the diagnosis of early onset of neurological disorders such as brain tumor and Alzheimers disease.